Abstract:OBJECTIVE:To observe the change in expression of Toll-like receptor 4 (TLR4) of splenic macrophage in patients with hypersplenism due to portal hypertension (PH), and investigate the role of TLR4 of splenic macrophage in hypersplenism. METHODS:Splenectomy was performed on 20 patients with hypersplenism due to PH (hypersplenism group) and 6 patients with rupture of spleen by trauma (control group) and the specimens of spleen were collected. The splenic macrophages were isolated by adhibit wall method. The expression of TLR4 of splenic macrophage was detected by immunohistochemical method (SABC), and the result was analyzed by the image analysis system. The phagocytosis of splenic macrophage was measured by chicken red blood cell (CRBC) phagocytosis assay. The level of serum endotoxin was detected before the operation by limulus assay. The results of these 2 groups were compared, and correlation analysis was made among different results of the hypersplenism group. RESULTS:The expression of TLR4 of splenic macrophage was 109 +/- 32 in the hypersplenism group, significantly higher than that of the control group (62 +/- 5, P < 0.01). The rate of phagocytosis and index of phagocytosis of splenic macrophage in the hypersplenism group were 12.6% +/- 3.0% and 0.146 +/- 0.035 respectively, both significantly higher than those of the control group (6.9% +/- 0.5% and 0.076 +/- 0.008 respectively, both P < 0.01) The level of endotoxin of the hypersplenism group was 0.28 EU/ml +/- 0.21 EU/ml, significantly higher than that of the control group (0.054 EU/ml +/- 0.014 EU/ml, P < 0.05). The rate of phagocytosis and the index of phagocytosis of splenic macrophage were notably positively correlated with the expression of TLR4 (r = 0.601, P < 0.01 and r = 0.553, P < 0.05), and the level of endotoxin (r = 0.724 P < 0.01 and r = 0.506, P < 0.05). The expression of TLR4 of splenic macrophage was positively correlated with the level of endotoxin (r = 0.525, P < 0.05). CONCLUSION:The expression of TLR4 of splenic macrophage in patients with hypersplenism due to PH was increased significantly. It may be one of the important factors of hypersplenism due to PH that "endotoxemia-->increase of expression of TLR4 of splenic macrophage (activation of TLR of splenic macrophage)-->increased destruction of red blood cells by macrophage".

Expression of NALP3 in the Spleen of Mice with Portal Hypertension

Changes in Splenic Macrophage Function of Hypersplenism Due to Portal Hypertension

Expression of Toll-like receptor 2,4 mRNA of splenic macrophage in hypersplenism due to portal hypertension

[Expression and Significance of Toll-like Receptor 4 of Splenic Macrophage in Patients with Hypersplenism Due to Portal Hypertension].

Changes in concentration and distribution of Ca~(2+) in splenic macrophage from hypersplenism due to portal hypertension

Cdna Microarray-Based Screening of Differentially Expressed Genes in Macrophages in the Spleen of Patients with Portal Hypertension and Hypersplenism

The role of splenomegaly and splenic macrophage in the occurrence of hypersplenism of portal hypertension

Hepatopulmonary Syndrome: the Role of Intra-Abdominal Hypertension and A Novel Mouse Model

Morphological Changes of Blood Spleen Barrier in Portal Hypertensive Spleen

Study of differential expression of cytokines between portal hypertensive hypersplenic tissue and normal splenic tissue by protein array

Changes of Number and Function of Iymphocytes in Spleen of Patients with Portal Hypertension

Endothelial Gab1 Deficiency Aggravates Splenomegaly in Portal Hypertension Independent of Angiogenesis.

Dynamical Changes of Spleen Following Portal Hypertension in Sprague-Dawley Rats by Portal Vein Stenosis

miR-615-3p promotes the phagocytic capacity of splenic macrophages by targeting ligand-dependent nuclear receptor corepressor in cirrhosis-related portal hypertension.

Effect of Splenectomy on Serum Cytokine Profiles in Hepatitis B Virus-Related Cirrhosis Patients with Portal Hypertension.

The lack of PPARα exacerbated the progression of non-alcoholic steatohepatitis in mice with spleen deficiency syndrome by triggering an inflammatory response

Expression and significance of NGAL in MRL/lpr lupus-prone mice

Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension.

Expression of transforming growth factor-β1 in splenic tissues of patients with hypersplenism of different etiopathogenisis and its significance

SPLUNC1 Knockout Enhances LPS-induced Lung Injury by Increasing Recruitment of CD11b+Gr-1+ Cells to the Spleen of Mice.

Effect of JAK2/STAT3 Signaling Pathway in the Spleen Fibrosis of Portal Hypertension